The SURPASS-5 study evaluated the efficacy and safety of an injectable mixture therapy: TZP and insulin glargine
Keywords: GLP-1, Cats, Dogs, Diabetes mellitus, Obesity, Incretin Abstract Analogues of glucagon like peptide-1 (GLP-1) and other drugs that increase this peptide half-life are used worldwide in human medicine to treat type 2 diabetes mellitus (DM) and obesity
Researchers who experience diminished results often attribute it to tolerance, receptor downregulation, or metabolic adaptation, when the actual cause is a degraded vial that is delivering less active peptide than expected
Liver problems may or may not respond well to treatment with L-carnitine
WE CAN HELP Please fill out the form below to be contacted for more information about the program
Carnitine Health Professional Fact Sheet